Combination therapy of hepatitis B.
Doo
E
E
Liver Diseases Section Digestive Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases Building 10, Room 9B06 NIH, Bethesda, MD 20892, USA. DooE@intra.niddk.nih.gov
Hoofnagle
J H
JH
D000998:Antiviral Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D019259:Lamivudine / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
D000998:Antiviral Agents; D016898:Interferon-alpha; D019259:Lamivudine